• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Collection of mobilized blood progenitor cells for hematopoietic rescue by large-volume leukapheresis.

作者信息

Comenzo R L, Vosburgh E, Weintraub L R, Tansan S, Arkin C F, Wright D G

机构信息

Department of Pathology and Clinical Laboratory Medicine, Boston University School of Medicine, Massachusetts, USA.

出版信息

Transfusion. 1995 Jun;35(6):493-7. doi: 10.1046/j.1537-2995.1995.35695288768.x.

DOI:10.1046/j.1537-2995.1995.35695288768.x
PMID:7770900
Abstract

BACKGROUND

Mobilized blood progenitor cells rapidly reconstitute hematopoiesis in patients after dose-intensive chemotherapy. However, optimal timing and methods of mobilized blood progenitor cell collection have yet to be fully defined.

STUDY DESIGN AND METHODS

The utility of large-volume leukapheresis (LVL; > 15 L blood processed) in collecting target doses of mononuclear cells (7 x 10(8)/kg) for use in autologous hematopoietic rescue was investigated. LVL was begun at a standardized interval (14 days) after a course of limited chemotherapy and subsequent daily recombinant human granulocyte-macrophage-colony-stimulating factor administration to mobilize blood progenitor cells into the circulation. With each LVL procedure, mononuclear cells, colony-forming units-granulocyte-macrophage (CFU-GM), burst-forming units-erythroid, mixed colonies, total clonogenic progenitor cells, and CD34+ cells collected per kg of patient weight were counted. After high-dose chemotherapy and infusion of cryopreserved mobilized blood progenitor cells, the days needed for neutrophils to reach levels of > 0.5 x 10(9) per L and for platelets to reach levels of > 20 x 10(9) per L were recorded.

RESULTS

In 14 previously treated cancer patients, an average of 28.9 +/- 4.9 L of blood was processed per LVL (n = 35) to collect medians of 2.5 x 10(8) mononuclear cells per kg (range, 1.0-7.4), 14 x 10(4) CFU-GM per kg (0-208), 27 x 10(4) clonogenic progenitor cells per kg (0-370), and 2.8 x 10(6) CD34+ cells per kg (0-112.5). Fifty-seven percent of patients (8/14) required one or two LVL procedures to collect adequate blood progenitor cells (range, 1-4). After dose-intensive chemotherapy, 13 patients received medians of 6.8 x 10(8) mononuclear cells per kg (range, 5.1-9.9), 53 x 10(4) CFU-GM per kg (9-208), and 12 x 10(6) CD34+ cells per kg (3.6-112.5). Rapid hematopoietic reconstitution occurred with 10 days (range, 8-12) and 9 days (6-15), respectively, for neutrophil and platelet recoveries.

CONCLUSION

Scheduled LVL, beginning on Day 14 after the administration of granulocyte-macrophage-colony-stimulating factor following chemotherapy, is a convenient and efficient method of collecting blood progenitor cells. The mononuclear cells so obtained effected consistent and rapid hematopoietic reconstitution in a highly reproducible manner in a group of heavily treated patients.

摘要

相似文献

1
Collection of mobilized blood progenitor cells for hematopoietic rescue by large-volume leukapheresis.
Transfusion. 1995 Jun;35(6):493-7. doi: 10.1046/j.1537-2995.1995.35695288768.x.
2
Optimal timing for collections of blood progenitor cells following induction chemotherapy and granulocyte-macrophage colony-stimulating factor for autologous transplantation in advanced breast cancer.晚期乳腺癌自体移植诱导化疗及粒细胞巨噬细胞集落刺激因子治疗后采集血液祖细胞的最佳时机。
Leukemia. 1993 Nov;7(11):1738-46.
3
Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization.环磷酰胺和粒细胞巨噬细胞集落刺激因子动员后采用单次大容量白细胞分离术进行外周血祖细胞采集的预测因素
J Clin Oncol. 1995 Mar;13(3):705-14. doi: 10.1200/JCO.1995.13.3.705.
4
Application of whole blood and peripheral blood progenitor cells (PBPC) and new strategies for rescue after intensive cyclic chemotherapy in high-risk breast cancer.全血和外周血祖细胞(PBPC)的应用以及高危乳腺癌强化周期化疗后挽救治疗的新策略。
J Hematother Stem Cell Res. 2000 Feb;9(1):31-8. doi: 10.1089/152581600319595.
5
Collection of more hematopoietic progenitor cells with large volume leukapheresis in patients with multiple myeloma.采用大容量白细胞分离术采集更多多发性骨髓瘤患者的造血祖细胞。
Leuk Lymphoma. 1998 Feb;28(5-6):501-8. doi: 10.3109/10428199809058357.
6
Large-volume leukapheresis yields more viable CD34+ cells and colony-forming units than normal-volume leukapheresis, especially in patients who mobilize low numbers of CD34+ cells.大容量白细胞单采术比常规容量白细胞单采术能产生更多有活力的CD34+细胞和集落形成单位,尤其是在动员出少量CD34+细胞的患者中。
Transfusion. 2005 Feb;45(2):248-53. doi: 10.1111/j.1537-2995.2004.04210.x.
7
Peripheral blood progenitor cell (PBPC) transplantation with a single apheresis in patients with lymphoma, myeloma and solid tumors.
Eur J Haematol. 1996 Oct;57(4):269-77. doi: 10.1111/j.1600-0609.1996.tb01377.x.
8
Impact of preleukapheresis cell counts on collection results and correlation of progenitor-cell dose with engraftment after high-dose chemotherapy in patients with germ cell cancer.白细胞单采前细胞计数对生殖细胞癌患者高剂量化疗后采集结果的影响及祖细胞剂量与植入的相关性
J Clin Oncol. 1996 Apr;14(4):1114-21. doi: 10.1200/JCO.1996.14.4.1114.
9
Improvement of hematologic recovery after high-dose intensification using peripheral blood progenitor cells (PBPC) mobilized by chemotherapy and GM-CSF.使用化疗和粒细胞巨噬细胞集落刺激因子(GM-CSF)动员的外周血祖细胞(PBPC)进行大剂量强化治疗后血液学恢复情况的改善。
Ann Hematol. 1994 Dec;69(6):297-302. doi: 10.1007/BF01696558.
10
Large-volume leukapheresis for collection of mononuclear cells for hematopoietic rescue in Hodgkin's disease.采用大容量白细胞单采术采集单核细胞用于霍奇金淋巴瘤的造血挽救治疗。
Transfusion. 1995 Jan;35(1):42-5. doi: 10.1046/j.1537-2995.1995.35195090659.x.

引用本文的文献

1
Therapeutic apheresis.
Indian J Pediatr. 2001 Jan;68(1):61-7. doi: 10.1007/BF02728865.